NOX1 and atopic eczema: In vitro studies have demonstrated that NOX4 is the main ROS source in human psoriatic fibroblasts and is essential for redox-mediated modulation of the metabolism in keratinocytes 90, while inhibition of NOX1 in keratinocytes derived from the skin of atopic dermatitis patients significantly reduced ROS production 91.